menu search

Famed "big short" investor loves this multibillion-dollar company -- should you?

Will Bristol-Myers squibbs' pipeline and newly approved drugs overcome its expiring patents?...

August 3, 2022, 8:32 am

These new blockbusters could fill bristol-myers squibb's revenue gap

A looming patent cliff puts pressure on the company's newest products....

July 28, 2022, 10:37 am

Bristol-myers squibb company (bmy) ceo giovanni caforio on q2 2022 results - earnings call transcript

Bristol-Myers squibb Company (NYSE:BMY ) Q2 2022 Earnings Conference Call July 27, 2022 8:00 AM ET Comp...

July 27, 2022, 11:17 am

How these acquisitions are changing the outlook for bristol myers squibb

The company is reshaping and expanding its oncology portfolio....

July 21, 2022, 5:41 am

What to expect from bristol myers squibb stock after q2 results?

Bristol Myers squibb (NYSE: BMY) is scheduled to report its Q2 2022 results on Wednesday, July 27. We e...

July 19, 2022, 8:45 am

2 biotech stocks that could soar in the third quarter

Bristol Myers squibb and Bluebird Bio have drugs in their pipelines that could soon earn FDA approval....

July 2, 2022, 5:41 am

Bristol myers must face $6.4 billion lawsuit over delayed cancer drug

A U.S. judge on Friday refused to dismiss a $6.4 billion lawsuit accusing Bristol Myers squibb Co of de...

June 24, 2022, 2:52 pm

Biotech etfs strengthen as bristol myers squibb buys turning point

Biotechnology sector-related exchange traded funds were in a bright spot on Friday after Bristol Myers squibb<...

June 3, 2022, 6:51 pm

Tptx stock soars 115% as bristol myers announces takeover of turning point therapeutics

Turning Point Therapeutics (TPTX) stock is rocketing higher on Friday following news of a deal with Bristol-Myers ...

June 3, 2022, 10:43 am

Why bristol-myers squibb (bmy) is buying turning point therapeutics (tptx) in a $4.1 billion deal

Bristol Myers squibb (NYSE: BMY) is buying Turning Point Therapeutics, Inc. (NASDAQ: TPTX) in a $4.1 bi...

June 3, 2022, 7:19 am

Turning point therapeutics stock more than doubles after bristol myers buyout deal valuing company at $3.8 billion

Shares of Turning Point Therapeutics Inc. TPTX, +2.21% more than doubled, up 116.7%, in premarket trading Friday, after the clinical-stage oncology co...

June 3, 2022, 7:14 am

Three-stock lunch: kinder morgan, m&t bank and bristol-myers squibb

Steve Grasso, Grasso Global CEO and CNBC contributor, joins 'Power Lunch' to discuss Grasso's thoughts on stocks like Kinder Morgan, M&T Bank and Bris...

June 2, 2022, 3:38 pm

Bristol-myers squibb company (bmy) ceo giovanni caforio presents at bernstein 38th annual strategic decisions conference (transcript)

Bristol-Myers squibb Company (NYSE:BMY ) Bernstein 38th Annual Strategic Decisions Conference Call June...

June 2, 2022, 2:09 pm

Bristol myers squibb, immatics expand car-t agreement

Shares of Immatics IMTX, +3.85% gained 9.0% in premarket trading on Thursday after the company said its deal with Bristol Myers ...

June 2, 2022, 7:44 am

Bristol myers squibb: a safe spot for a worrisome investor

Bristol Myers squibb is growing rapidly and can serve as a safe haven for investors worried about the c...

May 28, 2022, 3:35 am

Bristol myers squibb vs. abbvie: who better fits our barbell?

Both Bristol Myers squibb and AbbVie spark interest for income- and value-oriented investors. You will ...

May 25, 2022, 1:37 pm

Bristol-myers squibb: a safe haven in times of uncertainty

Geopolitics and risk of economic recession in the U.S. is forcing investors to look for defensive stocks, which refer to health care sector. Healthcar...

May 20, 2022, 6:06 pm

Bristol-myers squibb snags another approval for this mega-blockbuster drug

The EC has approved its cancer drug Opdivo, together with chemotherapy, to treat esophageal cancer....

May 7, 2022, 11:07 am

Bristol myers q1 earnings surpass street expectations, lowers fy22 guidance

Bristol-Myers squibb Co (NYSE: BMY) has posted Q1 revenues of $11.65 billion, an increase of 5% Y/Y (...

April 29, 2022, 8:20 am

Bristol myers 1st-quarter sales up on eliquis, opdivo

Drugmaker Bristol Myers squibb posted slightly better-than-expected first-quarter earnings on Friday on...

April 29, 2022, 7:04 am


Search within

Pages Search Results: